These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20460981)

  • 1. Influence of cinnamaldehyde on viral myocarditis in mice.
    Ding Y; Qiu L; Zhao G; Xu J; Wang S
    Am J Med Sci; 2010 Aug; 340(2):114-20. PubMed ID: 20460981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparison of α-bromo-4-chlorocinnamaldehyde and cinnamaldehyde on coxsackie virus B3-induced myocarditis and their mechanisms.
    Zhang Y; Cao W; Xie YH; Yang Q; Li XQ; Liu XX; Wang SW
    Int Immunopharmacol; 2012 Sep; 14(1):107-13. PubMed ID: 22709476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
    Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
    Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulation.
    Gui J; Chen R; Xu W; Xiong S
    J Cell Mol Med; 2015 Apr; 19(4):850-64. PubMed ID: 25728713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice.
    Jiang Y; Zhu Y; Mu Q; Luo H; Zhi Y; Shen X
    Antiviral Res; 2017 May; 141():133-139. PubMed ID: 28115196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
    J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melittin ameliorates CVB3-induced myocarditis via activation of the HDAC2-mediated GSK-3β/Nrf2/ARE signaling pathway.
    Wang T; Zhang J; Xiao A; Liu W; Shang Y; An J
    Biochem Biophys Res Commun; 2016 Nov; 480(1):126-131. PubMed ID: 27693786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of STAT3 inhibited the NF-ΚB signalling pathway and reduced inflammatory responses in mice with viral myocarditis.
    Li Z; Wang C; Mao Y; Cui J; Wang X; Dang J; Wang S
    Int Immunopharmacol; 2021 Jun; 95():107534. PubMed ID: 33752081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
    Qian H; Liu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halofuginone alleviates acute viral myocarditis in suckling BALB/c mice by inhibiting TGF-β1.
    Sun XH; Fu J; Sun DQ
    Biochem Biophys Res Commun; 2016 Apr; 473(2):558-64. PubMed ID: 27021682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
    Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
    Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response.
    Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K
    J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb/c Mice.
    Chen J; Yang F; Shi S; Liu X; Qin F; Wei X; Huang Y; Liang W; Miao L
    Mediators Inflamm; 2021; 2021():5551578. PubMed ID: 34093086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
    Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
    J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effect of hydrogen sulfide on mice with experimental viral myocarditis and its mechanism].
    Qian H; Liu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):708-12. PubMed ID: 25001934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
    Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
    Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of IFN-lambda2 on apoptotic protein in the myocardium in mice with viral myocarditis].
    Nie YJ; Huang XY; Wang SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):296-300. PubMed ID: 19374816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CaMKIIδ, Stabilized by RNA N6-Methyladenosine Reader IGF2BP2, Boosts Coxsackievirus B3-Induced Myocardial Inflammation via Interacting with TIRAP.
    Xiao Q; Liu L; Qian W; Kang T; Ying R; Nie J
    J Cardiovasc Transl Res; 2024 Jun; 17(3):540-553. PubMed ID: 38229002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.